Question 1

What EU grants are available for the Biotechnology sector?

Accepted Answer

The European Commission offers a wide range of funding opportunities specifically designed for the Biotechnology sector. These include grants through Horizon Europe (the EU's flagship research and innovation programme with a budget of €95.5 billion), the European Innovation Council (EIC) which provides funding for breakthrough innovations, and various sector-specific initiatives. Funding types range from Research and Innovation Actions (RIA) with 100% funding rates, to Innovation Actions (IA) with 70% funding for companies, and Coordination and Support Actions (CSA) for networking and coordination activities. Our database helps you find grants that match your organization's specific needs, project stage, and funding requirements.

Question 2

How do I apply for Biotechnology grants from the EU?

Accepted Answer

Applying for EU grants in the Biotechnology sector involves several key steps. First, use Grantalist to identify suitable open calls that match your project idea and organization type. Next, carefully review the call documentation, including eligibility criteria, evaluation criteria, and the work programme. Most EU grants require you to form a consortium with partners from at least 3 different EU member states or associated countries. Once ready, you'll submit your proposal through the EU Funding & Tenders Portal, which includes a detailed description of your project, work packages, budget breakdown, and impact assessment. The evaluation process typically takes 3-5 months, after which successful applicants enter grant agreement preparation. We recommend starting your application at least 2-3 months before the deadline.

Question 3

What is the typical funding amount for Biotechnology EU grants?

Accepted Answer

EU grants for the Biotechnology sector offer diverse funding levels depending on the programme and action type. Small-scale grants through programmes like EIC Accelerator can start from €500,000 up to €2.5 million in grant funding, plus up to €15 million in equity investment. Collaborative research projects under Horizon Europe typically range from €3 million to €10 million for standard projects, while some large-scale flagship initiatives can exceed €20 million. SMEs and startups often benefit from higher funding rates (up to 70% for Innovation Actions compared to large companies) and access to specialized instruments. The exact amount depends on the specific call topic, project scope, consortium size, and type of activities proposed.

Question 4

Who is eligible for Biotechnology EU grants?

Accepted Answer

Eligibility for Biotechnology EU grants extends to a wide range of organizations. Legal entities from EU member states and associated countries (including the UK for some programmes, Norway, Switzerland, and others) are typically eligible. This includes universities and research institutions, large enterprises and multinational corporations, small and medium-sized enterprises (SMEs) with fewer than 250 employees, startups and scale-ups, public bodies and NGOs, and international organizations. Some calls specifically target certain organization types, such as SME-only calls or academic-focused research grants. Third-country participation is possible in many programmes, though often without EU funding.

EU Grants for Biotechnology

Governing global commons sustainably

Understanding the forms of local democracy in low-income and low-middle income countries

Monitoring soil health in practice: equipping stakeholders to sample, analyse, and interpret soil health indicators

Antimicrobial resistance and antibiotic biosynthesis in soils: developing key understanding and counteractive strategies using a One-Health approach

Bridging the gap between disaster risk management and climate adaptation

Joint demonstration of solutions to build soil resilience to extreme weather events and support food security

Strengthened implementation of the EU Pact on Migration and Asylum and a focus on inclusion, integration, and health

Teaming Synergies

Research Management Facility

Hop-On Facility

Self-protection systems

Geopolitical competition and socioeconomic resilience in CCAM: an innovation and policy roadmap for EU leadership (CCAM Partnership)

Integrated Production and Product Development for Next-Generation Lithium-based Batteries for Mobility (BATT4EU and Made in Europe Partnerships)

Supporting sustainable and smart urban mobility in Europe (CIVITAS)

Road Safety and resilience of rural areas

Transition to low-temperature heating solutions in multi-apartment buildings

Increasing competitiveness and resilience of multimodal freight transport and logistics for competitive supply chains

Co-funded European Partnership for Social Transformations and Resilience

Accessible and available travel facilitation

Climate security and civil preparedness – new ways to develop pre- and post-crisis climate-change related scenarios for a more resilient Europe

Multi-hazard approach and cumulative / cascading impacts

Advanced border surveillance and situational awareness

Targeted innovative capabilities for the resilience of critical entities to natural and human-induced disasters, including hybrid scenarios

Open topic on driving innovation uptake of disaster risk solutions

Open topic on supporting disruptive technological innovations for civil security

Development of innovative tools, processes, equipment and technologies through responses to disasters and emergencies for search and rescue in hazardous conditions

Improving capabilities of law enforcement to counter climate-related challenges

Prevention and mitigation of misuse of synthetic biology for bioterrorism purposes

Missing persons: prevention and investigation

Demand-led innovation in security

Frequently Asked Questions About Biotechnology EU Grants